TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Knowledge about happiness
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Major deviations from good SBRT practice
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LVEF levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: RFS prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of death within 3 months
Endpoint domain: Mortality/survival
Primary endpoint: Motor experiences of daily living
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global sleep quality
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Cumulative complete responses after 52 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time to relapse in complete responders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of clinical failure
Endpoint domain: Mortality/survival
Primary endpoint: Need for noninvasive ventilation (NIV), mechanical ventilation (MV), or death
Endpoint domain: Mortality/survival
Primary endpoint: reductions in % body fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS for leg pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of PI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BMD at lumbar spine and left hip neck
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Monitoring visits received by PPMVs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: age-related depressive symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Allergy symptom score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to reach maximal concentration of 25(OH)D3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bioavailability of vitamin D3 and 25(OH)D3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction rate with analgesic effect
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: NPI-apathy score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DAIR score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DCA diagnostic criteria met
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean score in quizzes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Application subscore in the final exam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Students’ perceptions concerning promotion of learning interests, radiology skills, and diagnostic reasoning
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prolonged oxygen demand
Endpoint domain: Adverse events/effects
Primary endpoint: CDAI-LDA achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Fib‐4 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cervical extension range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: disability-adjusted life years (DALYs) averted
Endpoint domain: Mortality/survival
Primary endpoint: incremental cost-effectiveness ratio (ICER) per DALY averted
Endpoint domain: Resource use
Primary endpoint: Time spent in CKD stages 1-3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Prevention of deaths
Endpoint domain: Mortality/survival
Primary endpoint: Initiation of kidney replacement therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Use of dexamethasone among mechanically ventilated patients
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Use of remdesivir among hospitalized COVID-19 patients
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: dysfunctional attitudes
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: abnormal mental behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neurological sequelae
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Time to reach primary outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stone clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in asthma symptom days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative total HOPE-score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: ratio of VGCL/ML
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean total direct costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: incidence of postanesthesia complications
Endpoint domain: Adverse events/effects
Primary endpoint: Loss of muscle mass (CSA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Loss of muscle function (MT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Loss of muscle strength (KES)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute neutrophil count <1000 cells/mm3 (Grade 3/4 neutropenia)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Sustained clinical efficacy over 5 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: e-mail view rate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: DLQI
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: EQ‐5D‐5L‐PSO
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: PSI
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ≥50% reduction in MCSF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative fold change of TERT gene expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative fold change of TNF α gene expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postprandial GLP-1 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Total stroke
Endpoint domain: Mortality/survival
Primary endpoint: Hemorrhagic stroke
Endpoint domain: Mortality/survival
Primary endpoint: intact survival
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of participants achieving ≥50% reduction in monthly migraine days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvements in disability and quality-of-life outcomes
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Association with Alzheimer's disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Association with intelligence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Association with brain volume measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Faces Anxiety Scale scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: respiration rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: higher quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Relieving the cluster
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvements in physical well-being
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Head and neck cancer-specific QOL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incremental cost-effectiveness ratio for one additional successfully treated child
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: follow-up questionnaire completion rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: time from mannitol administration to dural opening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subdural ICP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BRS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BFI worst fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Mean visual analog scale pain scores with movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 10MWT time decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in oral health assessment tool scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clearance rates for Staphylococcus, Escherichia coli, and Pseudomonas aeruginosa
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Rates of rehospitalization for any cause
Endpoint domain: Mortality/survival
Primary endpoint: mean drain duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of infections requiring antibiotics
Endpoint domain: Adverse events/effects
Primary endpoint: rate of unplanned returns to the operating room
Endpoint domain: Adverse events/effects
Primary endpoint: max oxygen uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: LV myocardial stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Middle Ear Structural Visibility Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DA index differences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response rate to antithrombotic therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tolerance at 1 month after TURB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: frequency of WP smoking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perceived dementia-care competence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean number of LNs retrieved
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LN noncompliance rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of fluorescence imaging for detecting metastatic LN stations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete occlusion of polypoidal lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of completely intact sealants and those with minimal loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incisional hernia development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Autism symptoms improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional Emotional Development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nickel content in cereal grains and products
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: cycle length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: luteal-phase serum progesterone concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: mean PVR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: elicitation rate of nystagmus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: effectiveness of repositioning procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in CFU/mL values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of denture stomatitis (DS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difficulties in social and/or role functioning
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Distance covered in the Incremental Shuttle Walk Test (ISWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Differentiation between preentrustable and entrustable learners
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-assessment of hyperpigmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: overall satisfaction of the treatment outcome
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of potentially inappropriate prescribing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PET-negative rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impulsive features
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Unmet existential needs when prescribed cardiovascular preventive medication
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Area under the curve (AUC) of FE'ISO
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IVAS pain scores at 1 hour
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: prevalence rate of multiple sclerosis
Endpoint domain: Mortality/survival
Primary endpoint: mean annual number of new cases receiving MS diagnosis
Endpoint domain: Mortality/survival
Primary endpoint: percentage of patients receiving disease modifying therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delay of clinic visits for contraception
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Preference to avoid pelvic examinations
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: median intracranial progression-free survival
Endpoint domain: Mortality/survival
Primary endpoint: grade 3+ toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: monthly itch score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Post-PFT stress rating
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Performance on PFTs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: social effects
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Prognostic mortality of patients with progressive ischemic stroke
Endpoint domain: Mortality/survival
Primary endpoint: Changes in echocardiographic indexes of HF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Serum levels of N terminal pro brain natriuretic peptide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of participants completing ACP activities
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Improvement on the National Institutes of Health Stroke Scale (NIHSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: rehospitalization due to unstable angina
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Median reduction in SARS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: annualized moderate-severe exacerbation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Reinfection rate in osteomyelitis patients
Endpoint domain: Adverse events/effects
Primary endpoint: Failed wound healing rate
Endpoint domain: Adverse events/effects
Primary endpoint: Reulceration rate
Endpoint domain: Adverse events/effects
Primary endpoint: Development of PE within 7 days of screening
Endpoint domain: Mortality/survival
Primary endpoint: Quality of Life (QOL) as measured by MG-QOL15
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Distance covered in 6-Minute Walk Test (6MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: waiting time satisfaction scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Risk of iron deficiency based on ferritin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: target vessel myocardial infarction
Endpoint domain: Mortality/survival
Primary endpoint: time to 1st rescue analgesic consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: postoperative pain scores (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maternal arterial blood gas parameters (pH, pCO2, lactate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Major cardiovascular events (MACEs)
Endpoint domain: Mortality/survival
Primary endpoint: Prevalence of disability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood lactate concentrations at recovery minute 20
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Patient safety risk mitigation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WASI Full Scale IQ Z-score decline
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: average rsFC within the DMN and FPN
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of steps executed correctly
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to complete procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scores in global assessment categories
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: AOU of MAL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Usage of unaffected side
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: long-term recurrence and progression
Endpoint domain: Mortality/survival
Primary endpoint: Responsiveness of QI set for rehabilitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EVN scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean opioid consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Choice of intensive lifestyle change
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Choice of metformin
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Total volume of required saline for adequate distention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ICIQ-UI SF mean score improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ICIQ-OAB mean score improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ICIQ-LUTSqol mean score improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: violent reconviction rate
Endpoint domain: Mortality/survival
Primary endpoint: Herd effect against HPV16/18
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: stool-incontinence frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: stool type
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: pelvic floor excursion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: myogenic activities of the external anal sphincter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion of outcome assessment follow-up visits
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: HRQL-physical subdomain score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Hydrogen and methane concentrations in expired air
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: FHP (Functional Health Profile)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Jejunal glucose absorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Requirement for assistance to perform intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Ongoing pregnancy rate (OPR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Patient tolerability score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: viscosity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peroxide concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DPDD (Days Per Drink Day)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HDD (Heavy Drinking Days)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DPD (Drinks Per Day)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes